Intervention effectmodel-written summary

Validamycin (Sheathmar) gave 95.4% growth inhibition of the test pathogen, equally effective as tricyclazole + propiconazole

A claim from Efficacy of Tebuconazole Against Rhizocfonia solani, Causal Agent of Rice Sheath Blight · 2008

Intervention effectobservedoriginal resultpositivemeasured

Claim · model-written summary

Validamycin (Sheathmar) gave 95.4% growth inhibition of the test pathogen, equally effective as tricyclazole + propiconazole

Treatment
validamycin (Sheathmar)e6
Outcome
growth inhibitione6
Direction
equally effectivee6
Value
95.4%e6
Comparator
tricyclazole + propiconazole (Filia)e6

Not reportedMaterialGeneCompoundOrgan / stageInteractorInteractor roleSecond interactorSecond interactor roleSettingQualifier

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Oryza sativa
Oryza sativa · Taxon · picture from its Wikimedia Commons categoryDesmanthus4food · CC BY-SA 3.0 us · Wikimedia Commons ↗

Verbatim

t0

“Efficacy of Tebuconazole Against Rhizocfonia solani, Causal Agent of Rice Sheath Blight”

✓ located verbatim in the source · title, characters 0–87
e6

“The fungicides viz., tricyclazole + propiconazole (Filia) and validamycin (Sheathmar) were equally effective with 97.8% and 95.4% growth inhibition of the test pathogen”

✓ located verbatim in the source · abstract, characters 427–595

Title

Efficacy of Tebuconazole Against Rhizocfonia solani, Causal Agent of Rice Sheath Blight

S. Krishnam Raju; K. V. K. Kumar; M Ramabhadra Raju Indian journal of plant protection 2008

Other claims from this paper (8)

Record rev-e9dba88c1b969a752a162322ba82c55671eec1e17dd8de34ee027ed55d3bdb11 · schema claims-v0.9 · position 8 in the model’s answer

validamycin A · disease · Oryza sativa (rice)Results agree

8 papers: 8 positive, 0 negative or no effect

7 papers in the same direction as this claim

  1. positive
  2. positive
  3. positive
  4. positive
  5. positive
  6. positive
  7. positive
See all 8 papers →

Claims are grouped by organism, treatment and what was measured or targeted. A paper counts as positive when any of its claims in the group is positive.